‘Front of the line’: For Alzheimer’s patients in successful trial, a feeling of gratitude
(By Andrew Joseph for ST A T) When the news came out last month that an experimental Alzheimer’s therapy succeeded
Read More(By Andrew Joseph for ST A T) When the news came out last month that an experimental Alzheimer’s therapy succeeded
Read More(By Damian Garde for ST A T) The Food and Drug Administration approved a new medicine for ALS from Amylyx
Read More(By Andrew Joseph for ST A T) The news Tuesday night that a clinical trial of an experimental Alzheimer’s therapy
Read More(By Judith Graham for Kaiser Health News) During the past decade, a growing body of research has shown that air
Read More(By Mackenzie Bean for Becker’s Hospital Review ) Adults 65 and older who contract COVID-19 may be at greater risk
Read MoreBy Jonathan Wosen for STAT News on September 14, 2022 While pharma companies struggle to show that cutting-edge therapies can
Read MoreBy Jon Hamilton for NPR on September 12, 2022 In some families, Alzheimer’s disease seems inevitable. “Your grandmother has it,
Read More(By Megan Molteni for ST A T) Sending weak electrical current into the brain for 20 minutes a day for
Read More(By Judith Graham for Kaiser Health News) Eight months after falling ill with covid-19, the 73-year-old woman couldn’t remember what
Read More(By Jon Hamilton for NPR) The field of Alzheimer’s research is branching out. After decades of focusing on the sticky
Read More